Chemicals that attract specialized immune cells toward tumors could be used to develop better immunotherapies for cancer patients, according to new research. Scientists have discovered that immune cells called Natural Killer cells accumulate in tumors and release chemicals that attract specialized dendritic cells (cDC1) — white blood cells known for triggering anti-cancer immune responses — to the tumor.